Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fierce Biotech Homepage
Biotech
Novo inks $600M NanoVation deal to study genetic drugs ex-liver
Novo Nordisk agreed to pay NanoVation up to $600 million to collaborate on programs built on technology for targeting cells outside the liver.
Nick Paul Taylor
Sep 18, 2024 9:03am
Fierce 50 of 2024
Sep 9, 2024 5:02am
Akeso, Summit's PD-1 bispecific crushes Merck's Keytruda in study
Sep 8, 2024 11:30am
Aadi lays off 80% of R&D workforce as Fyarro heads to ph. 2 fail
Aug 21, 2024 4:51am
After SPAC deal fell flat, Visiox acquired by fellow eye biotech
Aug 19, 2024 10:45am
Opdivo maker Ono pays $2.4B for Deciphera
Apr 29, 2024 8:55am
Medtech News
Bayer, Daiichi, argenx leaders on navigating the AI 'hype cycle'
Sep 18, 2024 6:00am
Ramarketing hires head of data and insights to bolster AI work
Jul 2, 2024 11:02am
HCPs want AI to personalize, summarize medical education content
Jun 27, 2024 1:00am
'The rise of the customer is really important': Lions jury
Jun 20, 2024 5:39am
See More Medtech News
